Faculty

Joanne D. Stekler

Adjunct Professor, Epidemiology
Professor, Medicine - Allergy and Infectious Dis.
Adjunct Professor, Global Health

206-744-8312

Education

BA Biology, Williams College, 1992
MD Medicine (MD), Duke University, 1997
MPH Epidemiology, University of Washington, 2004

Contact

206-744-8312

University of Washington
Box 359931
Division of Allergy & Infectious Diseases
Harborview Medical Center
325 Ninth Avenue
Seattle, WA 98104

Research Areas

Research Interests

Dr. Joanne Stekler's research centers on HIV testing and HIV prevention. She is a national expert on HIV tests, particularly focused on acute HIV infection and point-of-care testing. She started the first community-based clinic for HIV pre-exposure prophylaxis (PrEP) in Seattle and is currently working to increase access to PrEP and PrEP adherence across Washington State.

Recent Publications (PubMed)

Impact of HIV self-testing for oral pre-exposure prophylaxis scale-up on drug resistance and HIV outcomes in western Kenya: a modelling study.
(2024 Jan 29)
Lancet HIV
Cox SN, Wu L, Wittenauer R, Clark S, Roberts DA, Nwogu IB, Vitruk O, Kuo AP, Johnson C, Jamil MS, Sands A, Schaefer R, Kisia C, Baggaley R, Stekler JD, Akullian A, Sharma M

Efficient Expansion of a Behavioral Survey to Assess Sex, Gender, and Behavioral Risk Among Transgender and Nonbinary Individuals: HMU! (HIV Prevention for Methamphetamine Users).
(2023 Oct)
Transgend Health 8(5): 472-476
Frank N, McMahan VM, Violette LR, Martin A, Glick SN, Stekler JD

Preferences for and Experiences of an HIV-Prevention Mobile App Designed for Transmasculine People: Pilot Feasibility Trial and Qualitative Investigation.
(2023 Sep 21)
JMIR Form Res 7(): e51055
Jones J, Butler G, Woody M, Castel AD, Kulie P, Sheets M, Scheim AI, Reisner SL, Valencia R, Wang M, Stekler JD, Sullivan PS, Stephenson R

Buy or Build: Challenges Developing Consumer Digital Health Interventions.
(2023 Aug)
Appl Clin Inform 14(4): 803-810
Saver BG, Marquard JL, Gummeson J, Stekler J, Scanlon JM

Seroconversion, seroreversion, and serowaffling among participants initiating antiretroviral therapy in Project DETECT.
(2023 May)
Int J STD AIDS 34(6): 385-394
Stekler JD, Violette LR, Niemann LA, McMahan VM, Katz DA, Chavez PR, Clark HA, Cornelius-Hudson A, McDougal SJ, Delaney KP

Show complete publication list